Publications

Maguire J, Beard B, Meder K, Dey A, Macartney K, McIntyre P. Australian vaccine preventable disease epidemiological review series: invasive Haemophilus influenzae type b disease, 2000–2017. Communicable Diseases Intelligence. 2020;44. [Full text]

Wood N, Sharma K. Meningococcal B vaccines: advice for parents. Medicine Today. 2020;23:53–54 . [Abstract]

Gidding HF, Peng CQ, Graves S, Massey PD, Nguyen C, Stenos J, Quinn HE, McIntyre PB, Durrheim DM, Wood N. Q fever seroprevalence in Australia suggests one in twenty people have been exposed. Epidemiology and Infection. 2020;148:e18. [Full text]

Sellens E, Bosward KL, Norris JM, Wood N, Heller J, Graves S, Gidding HF. Coxiella burnetii seroprevalence in unvaccinated veterinary workers in Australia: Evidence to support Q fever vaccination. Zoonoses and Public Health. 2020;67(1):79-88. [Abstract ]

Jayasinghe S, Sheridan S, Macartney K. Herpes zoster vaccination in Australia: what’s available and who benefits? . Australian Prescriber. 2020;43:2–6 . [Full text]

Frank O, Bernardo C, Gonzalez D, Macartney K, Menzies R, Stocks N. Pneumococcal vaccination uptake among patients aged 65 years or over in Australian general practice. Human Vaccines & Immunotherapeutics 2020. doi.org/10.1080/21645515.2019.1682844 . [Full text - Epub]

Wolfenden L, Bolsewicz K, Grady A, McCrabb S, Kingsland M, Wiggers J, Bauman A, Wyse R, Nathan N, Sutherland R, Hodder RK, Fernandez M, Lewis C, Taylor N, McKay H, Grimshaw J, Hall A, Moullin J, Albers B, Batchelor S, Attia J, Milat A, Bailey A, Rissel C,. Optimisation: defining and exploring a concept to enhance the impact of public health initiatives. Health Research Policy and Systems. 2019;17 (108). doi:10.1186/s12961-019-0502-6. [Full text]

Oliver J, Thielemans E, McMinn A, Baker C, Britton PN, Clark JE, Marshall HS, Blyth CC, Francis J, Buttery J, Steer AC, Crawford NW and on behalf of the PAEDS investigators. Invasive group A Streptococcus disease in Australian children: 2016 to 2018 – a descriptive cohort study. BMC Public Health 2019;19:1750 doi:10.1186/s12889-019-8085-2. [Full text]

Newall AT, Wood JG, Chen C, McIntyre P, Beutels P. Reply to letter: Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia. Vaccine. 2019;52:7534. doi: 10.1016/j.vaccine.2019.09.108. [Full text]

Webster F, Gidding H, Matthews V, Taylor R, Menzies R. What isn’t measured isn’t done – eight years with no progress in Aboriginal and Torres Strait Islander adult influenza and pneumococcal vaccination. Australian and New Zealand Journal of Public Health. 16 October 2019. doi: 10.1111/1753-6405.12944 . [Full text]